Deepak Bhambere

Dr. Deepak Bhambere

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 June 2021 in Ars Pharmaceutica (Internet)
Verified
Journal Article
Open access
PDF file
MPMoreshwar Patil
Moreshwar Patil
PPPrashant Pandit
Prashant Pandit
PUPavan Bhausaheb Udavant
Pavan Bhausaheb Udavant
SSSandeep Sonawane
Sandeep Sonawane
DBDeepak Bhambere
Deepak Bhambere
Introducción: Etodolac se usa en el tratamiento del dolor agudo y la inflamación. Tiene baja solubilidad debido a la alta hidrofobia y se informa que tras la administración oral muestra alteraciones gástricas. Esto fomenta el desarrollo de formulación tópica en lugar de oral. Método: En este trabajo utilizamos el método de separación de fase de coacervación para el desarrollo del sistema vesicular cargado con etodolaco mediante el uso de tensioactivos no iónicos, colesterol y lecitina de soja. El diseño central compuesto (rotativo) se utilizó para optimizar las concentraciones de lecitina de soja, surfactante y colesterol. Las formulaciones preparadas se caracterizaron por análisis de tamaño de vesículas, potencial zeta, eficiencia de atrapamiento, permeación in vitro, permeación ex vivo y estudio antiinflamatorio. Resultados: Etodolac quedó atrapado con éxito en todas las formulaciones que tenían una eficiencia en el intervalo de 74,36% a 90,85%, siendo mayor a 4 ° C que a temperatura ambiente. Cuando se hidrata con agua, los niosomas se producen espontaneamente el rango de 54 a 141 (por mm cúbico). Los resultados del estudio de difusión in vitro revelaron que el etodolaco se liberó en un rango de 71,86 a 97,16% durante un período de 24 horas. El tamaño medio de vesícula de la formulación optimizada se encontró en 211,9 nm con un PDI de 0,5. Las respuestas observadas, es decir,% de eficacia de encapsulación y liberación de fármaco, fueron 74,12 y 95,08 respectivamente. El potencial zeta fue de -19,4 mV y reveló la estabilidad de la formulación, que fue confirmada adicionalmente por la ausencia de cambios en el contenido del fármaco y la liberación del fármaco después de los estudios de estabilidad. El% de inhibición en el volumen de la pata fue del 40,52% y del 43,61% para la prueba y el gel proniosómico comercializado. Conclusión: la formulación de gel proniosomal fue estable y podría mejorar el suministro de etodolaco a la piel debido a la excelente capacidad de permeación del sistema vesicular.

30 June 2022 in Biosciences Biotechnology Research Asia
Verified
Journal Article
Open access
SASapana Ahirrao
Sapana Ahirrao
DBDeepak Bhambere
Deepak Bhambere
KTKunal Todkar
Kunal Todkar
MPMoreshwar Patil
Moreshwar Patil
PKPallavi Khairnar
Pallavi Khairnar
ABAnagha Baviskar
Anagha Baviskar
Zolmitriptan is the antimigraine agent widely used for the treatment of the migraine. It shows the half-life of 2.5 – 3 h which indicate the frequent dosing to achieve proper pharmacological action of the drug. Gastro Retentive Drug Delivery System (GRDDS) is a common approach to decrease the dosing frequency and increase patient compliance, and delivery of drug through such an approach of floating tablet formulation will meet the requirement. This system showed substantial effect on the drug release through floating and swelling properties. The tablets were formulated by using direct compression technique along with hydrophilic polymers and gas generating system. In the preliminary trials, we observed that the tablets were within pharmacopeial limit. % Drug release of the formulations (F1 – F9) was studied up to 6 h and it was found from 52 to 91 %. The cumulative percentage drug release was inversely proportional to polymer concentrations of HPMC K100 M and PVP K 30. The batches follow Higuchi model of drug release which involves the diffusion mechanism. In-vitro dissolution studies showed good percent drug release, which is in accordance with robinson-errikson equation. Good buoyancy for additional 6 h, trailed by the diffusion.

20 March 2013 in Particulate Science and Technology
Verified
Journal Article
Closed access
DBDeepak Bhambere
Deepak Bhambere
BSBirendra Shirivastava
Birendra Shirivastava
PSPankaj Sharma
Pankaj Sharma
NBNisha Bukane
Nisha Bukane
PGParaag Gide
Paraag Gide
The aim of this article was to evaluate the potential of poly lactide-coglycolide (PLGA) nanoparticles (NPs) as carriers for controlling release of doxorubicin (DOX) via a spray drying technique. The challenge was to entrap a hydrophilic molecule into a lipophilic core molecule of PLGA. To achieve this objective, we modified conventional approach of drug loading to spray drying technique. The eight formulations of nanoparticles were prepared by modified double emulsion and solvent evaporation technique followed by spray drying using 23 factorial designs. PLGA (A) and PVA (B) and stirring speed (C) were used as independent variables where particle size (Y1), entrapment efficiency (Y2) and percentage of drug release at the 32 hour (Y3) were taken as dependant variables. The results showed that the method is easy and efficient for the entrapment of the drug as well as the formation of spherical nanoparticles. This modification improved DOX entrapment efficiency relative to controls real loadings up to 40%. The in vitro release studies indicated the DOX loaded PLGA nanoparticles provide controlled drug release over a period of 32 h. Hence, this investigation demonstrated the potential of the experimental design in understanding the effect of the formulation variables on the quality of DOX-PLGA nanoparticles.

25 December 2023 in Turkish Journal of Pharmaceutical Sciences
Verified
Journal Article
Open access
ABAnagha Baviskar
Anagha Baviskar
VKVivekanand Kashid
Vivekanand Kashid
SASapana Ahirrao
Sapana Ahirrao
DBDeepak Bhambere
Deepak Bhambere
MAManoj Akul
Manoj Akul
Objectives: The objective of the present study was to develop natural excipient-based solid lipid nanoparticles (SLN) of butenafine hydrochloride (BUTE) using a modified solvent emulsification technique and to evaluate the competence of aloe vera nanolipidgel in enhancing the penetration of BUTE. Materials and Methods: BUTE-SLNs were prepared using a 23 3 factorial design to correlate the effect of formulation components on the BUTESLN. Particle size, polydispersity index (PDI), zeta potential, entrapment performance, and drug loading were assessed in the formed SLNs. The fabricated BUTE-SLN was evaluated for transmission electron microscopy, fourier transform infrared spectroscopy, differential scanning calorimetry, and X-ray diffraction study studies and revealed the encapsulation of BUTE in lipid in the amorphous state. BUTE-SLN-based aloe vera gel was formulated and evaluated compared with the marketed product with respect to primary skin irritation, hydration, skin permeation, and antifungal activity. Results: The BUTE-SLN aloe vera gel, optimized for its formulation, features excellent slip properties and controlled drug release. DSC and XRD studies confirm its amorphous nature with effective drug entrapment. The gel provides enhanced skin deposition, improved antifungal activity, and reduced irritation. This makes it a cost-effective and innovative alternative to traditional dosage forms. BUTE-SLN promisingly showed no irritation, higher hydrating potential, slow and sustained release, and enhanced antifungal activity. With an aim to target deeper skin strata, minimize the side effects of drugs and symptomatic impact of fungal infection, and shorten the duration of therapy, BUTE-SLN was successfully prepared. The mean particle size and PDI were 261.25 +/- 2.38 nm and 0.268 +/- 0.01, respectively. Conclusion: BUTE-SLN gel offers improved topical delivery of BUTE with significantly higher compatibility and antifungal activity than the marketed formulation.

1 April 2026 in Asian Journal of Pharmaceutical Research and Health Care
Verified
Journal Article
Open access
DBDeepak Bhambere
Deepak Bhambere
SASapana P. Ahirrao
Sapana P. Ahirrao
STSnehal Rajendra Tidke
Snehal Rajendra Tidke
A BSTRACT: Background: Bifonazole is a poorly water-soluble imidazole antifungal agent whose therapeutic performance in topical therapy is often limited by poor aqueous solubility, inadequate dermal penetration, and suboptimal drug release from conventional formulations. Microemulsion-based gels (emulgels) offer a promising strategy to enhance drug solubilization, stability, and topical delivery. Aim and Objectives: To develop and optimize a bifonazole-loaded microemulsion-based gel (emulgel) with improved drug solubilization, stability, in vitro drug release, and dermal safety compared with a conventional marketed cream. Materials and Methods: Solubility screening was performed to select suitable oil, surfactant, and cosurfactant for microemulsion formulation. Microemulsions were optimized based on oil concentration, surfactant-to-cosurfactant ratio, and thermodynamic stability. The optimized microemulsion was incorporated into Hydroxy Propyl Methyl Cellulose (HPMC) K100M gel at polymer concentrations ranging from 1% to 2%. The prepared emulgels were evaluated for pH, viscosity, spreadability, drug content, in vitro drug diffusion, accelerated stability, and skin irritation. Results: Oleic acid exhibited the highest bifonazole solubility among the oils (60.48 mg/mL), while isopropyl alcohol (80.18 mg/mL) and Tween 80 (56.33 mg/mL) demonstrated superior solubilizing capacity among the cosurfactants and surfactants, respectively. The optimized microemulsion containing Tween 80 and Span 80 (1:1) showed a drug content of 88.24% and achieved 85.10% cumulative drug release after 5 h. Increasing the HPMC concentration from 1% to 2% increased viscosity (28,100–36,500 cP) and decreased spreadability (22.40–12.98 g/cm/s). The optimized emulgel containing 1% HPMC exhibited an 87.36 ± 0.23% cumulative drug release after 5 h, higher than that of the marketed cream (83.76 ± 0.30%). Accelerated stability studies showed less than 5% variation in formulation characteristics, and no signs of erythema or skin irritation were observed. Conclusion: The optimized bifonazole microemulsion-based gel demonstrated enhanced in vitro drug release, desirable rheological characteristics, good physicochemical stability, and excellent dermal tolerability. These findings suggest that the developed emulgel is a promising topical delivery system for improving bifonazole therapy and warrants further in vivo and clinical evaluation.

2 August 2022 in Current Applied Polymer Science
Verified
Journal Article
Closed access
PDF file
SASapana Ahirrao
Sapana Ahirrao
DKDurgesh Kale
Durgesh Kale
DBDeepak Bhambere
Deepak Bhambere
DKDinesh Kuber
Dinesh Kuber
Background: Many BCS Class II and IV drugs possess high therapeutic potential but shows less bioavailability due to poor solubility. Hence present study is focused on improvement of solubility and dissolution rate of poorly soluble drug; tinidazole. Methods: Solid dispersion of tinidazole were prepared with gelucire and poloxamer using various methods; kneading, fusion and solvent evaporation. Formulations were evaluated by saturation solubility, drug content, in vitro dissolution rate, FTIR, DSC, XRD and stability study. Optimised solid dispersions of gelucire and poloxamer provided dissolution rates faster than that of pure drug. Results: In vitro dissolution studies revealed that formulation batch Sg14 shows 94.43 percent drug release with a correlation coefficient (R²) of 0.949 and batch Sp14 shows 97.69 percent drug release with a correlation coefficient (R²) of 0.993. DSC study revealed that there was no interaction between drug and carrier whereas the XRD study of optimised formulation batches demonstrates that there was a significant decrease in crystallinity when compared with XRD pattern of pure drug tinidazole. Significant change in solubility and in vitro dissolution rate of tinidazole would be due to amorphous state maintained in the optimised formulation batches. Conclusion: Hence overall formulation and evaluation studies of present research work indicate that solid dispersion by solvent evaporation method is an effective means to improve the solubility of tinidazole.